Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
Biochemical and Biophysical Research Communications
|
June 29, 1990
Interleukin (IL)-8-induced in vitro human lymphocyte migration is inhibited by cholera and pertussis toxins and inhibitors of protein kinase C
K B Bacon, R D Camp
Expert Opinion on Investigational Drugs
|
November 4, 2000
Chemokine receptor antagonism as a new therapy for multiple sclerosis
R M Ransohoff, K B Bacon
Journal of Neuroimmunology
|
February 23, 2000
Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis
K B Bacon, J K Harrison
Current Opinion in Immunology
|
December 1, 1994
Chemokines, leukocyte trafficking, and inflammation
T J Schall, K B Bacon
Cytokine & Growth Factor Reviews
|
October 1, 1998
Chemokines in disease models and pathogenesis
K B Bacon, J J Oppenheim
Prostaglandins
|
December 1, 1990
Lipid lymphocyte chemoattractants in psoriasis
K B Bacon, R D Camp
International Archives of Allergy and Immunology
|
February 1, 1996
Chemokines as mediators of allergic inflammation
K B Bacon, T J Schall
Biochemical and Biophysical Research Communications
|
November 30, 1989
Potent and specific inhibition of IL-8-, IL-1 alpha- and IL-1 beta-induced in vitro human lymphocyte migration by calcium channel antagonists
K B Bacon, J Westwick, R D Camp
Immunology
|
July 1, 1993
Anti-CD40 antibody stimulates the VLA-4-dependent adhesion of normal and LFA-1-deficient B cells to endothelium
L Flores-Romo, D Estoppey, K B Bacon
The Journal of Investigative Dermatology
|
November 1, 1990
Lymphocyte chemoattractants in psoriasis and normal skin
R D Camp, K B Bacon, N J Fincham
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
Biochemical and Biophysical Research Communications
|
June 29, 1990
Interleukin (IL)-8-induced in vitro human lymphocyte migration is inhibited by cholera and pertussis toxins and inhibitors of protein kinase C
K B Bacon, R D Camp
Expert Opinion on Investigational Drugs
|
November 4, 2000
Chemokine receptor antagonism as a new therapy for multiple sclerosis
R M Ransohoff, K B Bacon
Journal of Neuroimmunology
|
February 23, 2000
Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis
K B Bacon, J K Harrison
Current Opinion in Immunology
|
December 1, 1994
Chemokines, leukocyte trafficking, and inflammation
T J Schall, K B Bacon
Cytokine & Growth Factor Reviews
|
October 1, 1998
Chemokines in disease models and pathogenesis
K B Bacon, J J Oppenheim
Prostaglandins
|
December 1, 1990
Lipid lymphocyte chemoattractants in psoriasis
K B Bacon, R D Camp
International Archives of Allergy and Immunology
|
February 1, 1996
Chemokines as mediators of allergic inflammation
K B Bacon, T J Schall
Biochemical and Biophysical Research Communications
|
November 30, 1989
Potent and specific inhibition of IL-8-, IL-1 alpha- and IL-1 beta-induced in vitro human lymphocyte migration by calcium channel antagonists
K B Bacon, J Westwick, R D Camp
Immunology
|
July 1, 1993
Anti-CD40 antibody stimulates the VLA-4-dependent adhesion of normal and LFA-1-deficient B cells to endothelium
L Flores-Romo, D Estoppey, K B Bacon
The Journal of Investigative Dermatology
|
November 1, 1990
Lymphocyte chemoattractants in psoriasis and normal skin
R D Camp, K B Bacon, N J Fincham
Page
of 7